Teva Pharmaceutical Industries Ltd (NYSE:TEVA)

62.30
Delayed Data
As of Mar 31
 -0.22 / -0.35%
Today’s Change
47.36
Today|||52-Week Range
64.08
+8.33%
Year-to-Date

Today’s Trading

Previous close62.52
Today’s open62.80
Day’s range61.94 - 63.47
Volume5,772,796
Average volume (3 months)4,690,470
Market cap$59.8B
Dividend yield2.18%
Data as of 4:01pm ET, 03/31/2015

Growth & Valuation

Earnings growth (last year)+136.23%
Earnings growth (this year)+1.51%
Earnings growth (next 5 years)+0.70%
Revenue growth (last year)-1.87%
P/E ratio17.5
Price/Sales2.45
Price/Book2.27

Competitors

 Today’s
change
Today’s
% change
DEPODepomed Inc-0.42-1.84%
NEPTNeptune Technologies...-0.04-2.41%
VBLTVascular Biogenics L...-0.09-1.70%
Data as of 3:59pm ET, 03/31/2015

Financials

Next reporting dateApril 30, 2015
EPS forecast (this quarter)$1.25
Annual revenue (last year)$20.0B
Annual profit (last year)$3.0B
Net profit margin15.07%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Erez Vigodman
President &
CEO-Global Operations
Carlo de Notaristefani
Corporate headquarters
Petach Tikva, --

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account